These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 17081079)

  • 21. Cardiac disease in chronic kidney disease: current understandings and opportunities for change.
    Levin A
    Blood Purif; 2004; 22(1):21-7. PubMed ID: 14732808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.
    Gansevoort RT; Correa-Rotter R; Hemmelgarn BR; Jafar TH; Heerspink HJ; Mann JF; Matsushita K; Wen CP
    Lancet; 2013 Jul; 382(9889):339-52. PubMed ID: 23727170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy for the altered mineral metabolism of chronic kidney disease: implications for vascular calcification.
    Saab G; Whaley-Connell AT; Khanna R; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Dec; 1(2):107-12. PubMed ID: 19124399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypertension and the kidney: perspectives on the relationship of kidney disease and cardiovascular disease.
    Weir MR
    Clin J Am Soc Nephrol; 2009 Dec; 4(12):2045-50. PubMed ID: 19608710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease.
    Kendrick J; Chonchol MB
    Nat Clin Pract Nephrol; 2008 Dec; 4(12):672-81. PubMed ID: 18825155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular Disease in Children and Adolescents With Chronic Kidney Disease.
    Weaver DJ; Mitsnefes M
    Semin Nephrol; 2018 Nov; 38(6):559-569. PubMed ID: 30413251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular complications in diabetic kidney disease.
    Patel T; Charytan DM
    Semin Dial; 2010; 23(2):169-77. PubMed ID: 20210914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arterial stiffness in chronic kidney disease: an update.
    Taal MW
    Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):169-73. PubMed ID: 24389732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epidemiology of chronic kidney disease].
    Noël D; Landais P
    Rev Prat; 2012 Jan; 62(1):38-42. PubMed ID: 22335065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Socio-economic disparities in the distribution of cardiovascular risk in chronic kidney disease stage 3.
    Fraser SD; Roderick PJ; McIntyre NJ; Harris S; McIntyre CW; Fluck RJ; Taal MW
    Nephron Clin Pract; 2012; 122(1-2):58-65. PubMed ID: 23548499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of non-dialysis-requiring chronic kidney disease and cardiovascular disease.
    Go AS; Lo JC
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):296-302. PubMed ID: 16609298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary calcification is associated with lower bone formation rate in CKD patients not yet in dialysis treatment.
    Tomiyama C; Carvalho AB; Higa A; Jorgetti V; Draibe SA; Canziani ME
    J Bone Miner Res; 2010 Mar; 25(3):499-504. PubMed ID: 19594321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic kidney disease (CKD) as an independent risk factor for cardiovascular disease (CVD)].
    Minami J; Ishimitsu T; Sudo Y; Matsuoka H
    Nihon Rinsho; 2008 Sep; 66(9):1657-63. PubMed ID: 18788391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study.
    Muiesan ML; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Salvetti M; Trimarco B; Volpe M; Pontremoli R; Deferrari G; Rosei EA
    J Hypertens; 2012 Dec; 30(12):2378-86. PubMed ID: 23137952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular disease in chronic kidney disease.
    Saran AM; DuBose TD
    Ther Adv Cardiovasc Dis; 2008 Dec; 2(6):425-34. PubMed ID: 19124439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence and prognostic implications of polyvascular atherosclerotic disease in patients with chronic kidney disease.
    van Kuijk JP; Flu WJ; Chonchol M; Welten GM; Verhagen HJ; Bax JJ; Poldermans D
    Nephrol Dial Transplant; 2010 Jun; 25(6):1882-8. PubMed ID: 20061315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection.
    Whaley-Connell A; Pavey BS; Chaudhary K; Saab G; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):27-35. PubMed ID: 19124393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk prediction in chronic kidney disease: pitfalls and caveats.
    Rigatto C; Sood MM; Tangri N
    Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):612-8. PubMed ID: 23042027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of oxidative stress on chronic kidney disease progression.
    Putri AY; Thaha M
    Acta Med Indones; 2014 Jul; 46(3):244-52. PubMed ID: 25348188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interrelationship between chronic kidney disease and risk of cardiovascular diseases.
    Hernandez GT; Sippel M; Mukherjee D
    Cardiovasc Hematol Agents Med Chem; 2013 Mar; 11(1):38-43. PubMed ID: 22721441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.